BridgeBio Pharma, Inc. (BBIO)
Market Closed
1 Sep, 20:00
$
76. 57
-0.02
-0.0261%
$
15B Market Cap
- P/E Ratio
- Div Yield
1.45M Volume
-3.85 Eps
$ 76.59
Previous Close 
Want to track BBIO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
BridgeBio Pharma, Inc. (BBIO) Statistics
Valuation metrics
Market Cap 15B
Enterprise value 16.82B
Trailing P/E (ttm) -21.4
Forward P/E 361.36
PEG ratio -1.66
Price/Sales (ttm) 21.69
Price/Book (mrq) -5.96
Enterprise Value/Revenue 24.31
Enterprise Value/EBITDA -27.9
Overview
Shares outstanding 194.77M
Float 160.8M
Shares short 23.37M
% Held by insiders 0.04%
% Held by institutions 1.01%
Average volume (10 days) 2.6M
Average volume (90 days) 2.47M
Price summary
52-Week low 48.78
52-Week high 93.42
Beta 1.09
50-Day moving average 80.97
200-Day moving average 71.12
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -1.01%
Operating margin -0.79%
Operational effectiveness
Return on assets -0.57%
Return on equity 0.32%
Income Statement
Revenue (ttm) 502.08M
Revenue per share (ttm) 3.53
Quarterly revenue growth (yoy) 25.21%
Gross profit (ttm) 481.11M
EBITDA -496.63M
Net income to common (ttm) -724.93M
Diluted EPS (ttm) -3.56
Quarterly earnings growth (yoy) 25.21%
Balance Sheet
Total cash (mrq) 587.48M
Total cash per share (mrq) 3.68
Total debt (mrq) 1.86B
Total Debt/Equity (mrq) -0.99
Current ratio (mrq) 1.23%
Book value per share (mrq) -12.8
Cash Flow
Cash flow statement -445.91M
Levered free cash flow (LFCF) -325.29M
